The SoundScar Study The SOUNDSCAR Study
SoundScar
UltraSOUND-based Characterization of Ventricular Tachycardia SCAR and Arrhythmogenic Substrate; The SOUNDSCAR Study
1 other identifier
observational
38
2 countries
2
Brief Summary
Prospective, Non-randomized, Single-arm Study to assess the accuracy of intracardiac echocardiography (ICE) for characterization of arrhythmogenic substrate in patients with ischaemic cardiomyopathy undergoing ventricular tachycardia (VT) ablation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2018
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 9, 2018
CompletedFirst Submitted
Initial submission to the registry
February 25, 2019
CompletedFirst Posted
Study publicly available on registry
March 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedOctober 4, 2023
October 1, 2023
2.4 years
February 25, 2019
October 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Areas of abnormal contraction (hypokinesia/akinesia) as determined by ICE imaging
Area with abnormal contraction as correlated the findings on voltage mapping (low voltage) of the left ventricle in patients with a prior myocardial infarction undergoing VT ablation.
1 week
Secondary Outcomes (1)
Areas of abnormal contraction as determined by ICE imaging
1 week
Eligibility Criteria
Patients with ischaemic cardiomyopathy undergoing ventricular tachycardia (VT) ablation
You may qualify if:
- Prior heart attack (myocardial infarction) with evidence from prior non-invasive imaging demonstrating regions of the heart with reduced heart muscle function (myocardial hypokinesia/akinesia/thinning) in the absence of a non-heart attack-related (non-ischaemic) cause
- Age over 18 years
- One of the following abnormal heart rhythm (VT) events within last 6 months:
- ≥3 episodes of VT treated with therapeutic rapid pacing from an implantable cardiac defibrillator (antitachycardia pacing \[ATP\])
- ≥1 appropriate shocks from an implantable cardiac defibrillator
- ≥3 episodes of abnormal heart rhythm (VT) within 24 hours
- Sustained VT below the detection rate of the implantable cardiac defibrillator (documented by ECG/cardiac monitor)
- Sustained abnormal heart rhythm (VT) in the absence of ICD which is documented by ECG/cardiac monitor
- Patients in whom ICE imaging is planned for the clinical VT ablation procedure (clinical indication)
You may not qualify if:
- Patient unable or unwilling to provide informed consent.
- Acute heart attack (acute coronary syndrome with acute thrombus diagnosed by coronary angiography, or dynamic ST segment changes demonstrated on ECG) or another reversible cause of abnormal heart rhythm (VT) - e.g. electrolyte abnormalities or drug-induced abnormal heart rhythms
- Ineligible for ablation (known to have protruding clot in the chamber of interest (left ventricular thrombus), or have implanted mechanical aortic and mitral valves)
- Had recent coronary bypass surgery (\< 3 months) or percutaneous coronary intervention (\<3 months)
- Pregnant patients (pregnancy test will be performed in patients who are of childbearing age who are not on an effective contraceptive prior to all VT ablation procedures)
- Had recent coronary bypass surgery (\< 3 months) or percutaneous coronary intervention (\<3 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Westmead Hospital
Sydney, New South Wales, Australia
Liverpool Heart and Chest Hospital NHS Trust
Liverpool, L14 3PE, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Saagar Mahida, MD
Liverpool Heart and Chest Hospital
- PRINCIPAL INVESTIGATOR
Sharad Agarwal, MD
Papworth Hospital NHS Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2019
First Posted
March 5, 2019
Study Start
November 9, 2018
Primary Completion
April 1, 2021
Study Completion
April 1, 2021
Last Updated
October 4, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share